203 related articles for article (PubMed ID: 22706980)
1. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
[TBL] [Abstract][Full Text] [Related]
2. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.
Sand M; Skrygan M; Georgas D; Arenz C; Gambichler T; Sand D; Altmeyer P; Bechara FG
Mol Carcinog; 2012 Nov; 51(11):916-22. PubMed ID: 22025453
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
[TBL] [Abstract][Full Text] [Related]
6. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
7. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
Schulz H
Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
[TBL] [Abstract][Full Text] [Related]
8. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
10. Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.
Zhang L; Xie Q; Shan SJ; Tabor MK; Junkins-Hopkins JM
Anticancer Res; 2015 Jun; 35(6):3185-91. PubMed ID: 26026078
[TBL] [Abstract][Full Text] [Related]
11. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
Ohnishi K; Ishikawa H
Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNA machinery proteins in different types of chronic rhinosinusitis.
Zhang YN; Cao PP; Zhang XH; Lu X; Liu Z
Laryngoscope; 2012 Dec; 122(12):2621-7. PubMed ID: 22961479
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
18. The microRNA molecular signature of atypic and common acquired melanocytic nevi: differential expression of miR-125b and let-7c.
Holst LM; Kaczkowski B; Glud M; Futoma-Kazmierczak E; Hansen LF; Gniadecki R
Exp Dermatol; 2011 Mar; 20(3):278-80. PubMed ID: 21166724
[TBL] [Abstract][Full Text] [Related]
19. [Thermographic examination of cutaneous melanocytic nevi].
Mikulska D
Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
